Navigation Links
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Date:1/30/2013

lignancies such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Results from a pilot Phase II clinical trial of Pracinostat in combination with azacitidine in patients with advanced MDS showed an overall response rate (CR+CRi+PR) of 90% (nine out of 10), including eight complete responses. The Company plans to initiate a randomized, placebo-controlled Phase II trial of Pracinostat in combination with azacitidine in patients with MDS by June 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and inte
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/6tdwh8/medical_device ) ... Device Outsourcing - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Device Outsourcing ... Class I, Class II, and Class III. The ... - Radiology, Orthopedic, Neurology, Cardiology, and Others. ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... , WAYNE, Pa., Nov. 20 Escalon Medical Corp. (Nasdaq ... ended September 30, 2009. , For the first ... 2.7%, to $8,435,000 during the three-month period ended September 30, ... The Company reported the decreased net revenue of $8,434,000 ...
... , LOUISVILLE, Ky., Nov. ... today announced a new initiative in the war on methamphetamine. ... electronic tracking program that enforces purchase limitations on over-the-counter (OTC) ... The technology for NPLEx is based on a system ...
Cached Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3
(Date:4/18/2015)... April 18, 2015 Carinsurancequotesinfo.com has released ... can cover physical injuries caused by a car ... financial coverage for a vehicle. A policy can pay ... an accident. Drivers should always carry appropriate coverage when ... policy can be bought with several important riders that ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 "I recognized ... stretchers in healthcare facilities," said an inventor from Cincinnati, ... storage system." , He developed the Slyde Door to ... used in healthcare facilities. It provides convenient storage space ... are more stretchers available for patients. , This ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Patients who ... of developing mesothelioma later in life, but the disease ... mesothelioma that is unrelated to radiation. Surviving Mesothelioma has ... its website. Click here to read it now. ... compared the cases of 45 patients who had both ...
(Date:4/18/2015)... More than 2000 styles of newly ... the #1 online store carrying celebrity inspired special occasion ... got their perfect dresses for their prom. For those ... dresses at TheCelebrityDresses.com would be an ideal choice. ... prom dresses inspired by the most loved styles seen ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... 2, 2008 Rochester,Medical Corporation (Nasdaq: ROCM ... now allows intermittent catheter users to benefit from,not ... 2008, the four regional Durable Medical Equipment,(DME) Medicare ... a new reimbursement policy covering the use of,Intermittent ...
... is being released by the National Association of Boards ... and convenient when,patients use legitimate online pharmacies, but it ... recipients of counterfeit drugs from,dishonest Web sites. The vast ... "buyer beware" situations as it is often difficult,for them ...
... ... Heroes, FORT WORTH, Texas, ... flight attendants who,have administered emergency medical attention by using onboard,defibrillators. Flight attendants ... to celebrate the lives saved and heroic,measures taken during medical emergencies inflight ...
... cancer incidence not clear yet, expert says , , WEDNESDAY, ... on chromosome 15 that has three nicotine receptor genes that ... finding offers yet more evidence that lung cancer is tied ... variants represent a direct risk for lung cancer and ...
... Mo., April 2, 2008 As the use ... threatened,with greater liability for loss associated with unauthorized ... Stuckey & Company gives critical,professional liability options that ... Their technology insurance program can give,both 1st and ...
... A substantial,proportion of the nation,s public school ... school students, some possibly going beyond,sanctions set by ... led by the,Pacific Institute for Research and Evaluation ... sports and extracurricular activities., The study, funded ...
Cached Medicine News:Health News:Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters 2Health News:Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs 2Health News:Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs 3Health News:American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony 2Health News:Gene Variants Linked to Lung Cancer Identified 2Health News:Gene Variants Linked to Lung Cancer Identified 3Health News:Gene Variants Linked to Lung Cancer Identified 4Health News:Digital Technology Exposes Business to Greater Liability 2Health News:Recent Study Finds That a Substantial Number of Public School Districts Conduct Random Drug Testing with High School Students 2
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
Core Malaria Pf is a rapid self performing, qualitative, two site sandwich immunoassay for the determination of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples...
Ultraview 1700 Central Monitor...
The Hypervisor VI is a solution for telemetry, LAN and wireless LAN networking. It includes bi-directional communication with Mindray bedside patient monitors and can store waveforms and numeric info...
Medicine Products: